Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / June / Mapping the FLIGHT Path
Glaucoma Research & Innovations Interview

Mapping the FLIGHT Path

How incision-free intervention could expand glaucoma treatment options

By Julian Upton 6/16/2026 5 min read

Share

  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions

Clinical Report: Mapping the FLIGHT Path

Overview

ViaLase has completed the first commercial femtosecond laser image-guided trabeculotomy procedures for open-angle glaucoma. This incision-free technology aims to improve aqueous outflow and reduce intraocular pressure, with initial results showing promising outcomes.

Background

The management of open-angle glaucoma is critical due to its chronic nature and potential for vision loss. Traditional treatments often involve medications and surgical interventions, which can have limitations. The introduction of femtosecond laser technology represents a significant advancement in glaucoma care, potentially offering a new, less invasive option for patients.

Data Highlights

No numerical data available in the source material.

Key Findings

  • The FLIGHT procedure is designed to create precise channels through the trabecular meshwork without incisional surgery.
  • Initial procedures were performed on 15 patients, with reports of no pain and a procedure duration of 2-3 minutes per eye.
  • FLIGHT may serve as an alternative for patients who do not achieve meaningful pressure reduction from repeated SLT.
  • The technology is intended to help keep patients off glaucoma drops longer, addressing issues of adherence and side effects.
  • FLIGHT is positioned to fit within a crowded glaucoma treatment pathway, potentially allowing earlier intervention in the disease process.

Clinical Implications

The FLIGHT procedure may provide a new option for glaucoma patients, particularly those who have not responded well to existing treatments. Its non-incisional nature and quick execution could enhance patient comfort and compliance.

Conclusion

The introduction of the FLIGHT procedure marks a promising development in glaucoma treatment, with early results suggesting it could complement existing therapies and improve patient outcomes.

Related Resources & Content

  1. American Academy of Ophthalmology, PubMed, 2026 -- Primary Open-Angle Glaucoma Preferred Practice Pattern®
  2. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial, Ophthalmology, 2022 -- Long-term randomized data
  3. A Novel Cardiac Mapping Approach Utilizing Active Learning for Enhanced Radiofrequency Catheter Ablation Efficiency
  4. Enhanced Reality Visualization for Automated Pathway Planning in Percutaneous Procedures: A Phantom Experiment
  5. the pathologist — Pathology Education in the Age of Copilots
  6. Sparse Catheter Pathways for Neural Network-Based Reconstruction of the Left Atrial Structure
  7. Primary Open-Angle Glaucoma Preferred Practice Pattern® - PubMed
  8. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial - Ophthalmology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: